Financial statements Apteka Elixir
Balance sheet of Apteka Elixir
Company age:
Age:
8 y. 3 m. 29 d.
Share capital:
Share capital:
273 200 PLN
Balance sheet data of APTEKA ELIXIR
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 729 695,80 | 877 340,63 | 1 185 896,36 | 1 762 225,27 |
| A. Fixed assets | 94 010,58 | 91 469,70 | 91 884,38 | 96 385,30 |
| B. Current assets | 635 685,22 | 785 870,93 | 1 094 011,98 | 1 665 839,97 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 729 695,80 | 877 340,63 | 1 185 896,36 | 1 762 225,27 |
| A. Equity | 307 935,89 | 433 777,62 | 543 393,02 | 378 909,10 |
| B. Liabilities and provisions for liabilities | 421 759,91 | 443 563,01 | 642 503,34 | 1 383 316,17 |
| I. Long-term liabilities | 0,00 | 68 589,00 | 107 827,60 | 326 674,00 |
| II. Short-term liabilities | 421 759,91 | 374 974,01 | 534 675,74 | 1 056 642,17 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.